Markets›Health care›DHR

Danaher

DHR
224.49
+0.72 (+0.32%)
Closing price for Sep 25, 2026 from Polygon.io
Income statement Balance sheet Cash flow | Annual Quarterly |Download CSV
Cash flow (USD) FY 2025
ended Dec 31, 2025
FY 2024
ended Dec 31, 2024
FY 2023
ended Dec 31, 2023
FY 2022
ended Dec 31, 2022
FY 2021
ended Dec 31, 2021
FY 2020
ended Dec 31, 2020
Net income 3.61B3.90B4.76B7.21B6.43B3.65B
Depreciation and amortization 750.00M721.00M2.17B2.13B2.06B1.77B
Stock-based compensation 298.00M288.00M306.00M295.00M184.00M187.00M
Cash from operations 6.42B6.69B7.16B8.52B8.36B6.21B
Capital expenditure -1.16B-1.39B-1.38B-1.12B-1.24B-791.00M
Free cash flow 5.26B5.30B5.78B7.40B7.12B5.42B
Acquisitions 0-558.00M-5.61B-582.00M-10.90B-20.97B
Cash from investing -1.20B-1.98B-7.08B-2.23B-12.99B-21.24B
Dividends paid -878.00M-768.00M-821.00M-818.00M-742.00M-615.00M
Share buybacks -3.09B-5.98B00
Cash from financing -2.96B-8.38B-273.00M-2.57B1.29B1.01B
Net change in cash 2.54B-3.79B-131.00M3.41B-3.45B-13.88B

From Danaher's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read cash flow or reading a 10-K.

Charts

Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.